Asia-based USD fund leads seed series investment in California life sciences start-up developing disease-associated targets using proteogenomic approach

"Jones Day advised an Asia-based USD fund in its lead seed series investment in a California life sciences start-up that is developing novel disease-associated targets discovered using a proteogenomic approach. The firm acted for the Asia-based fund in the lead position in the start-up’s seed financing."